SJ, great post and I too have been here a while, 3 + years
SJ, great post and I too have been here a while, 3 + years and sure, it's quite difficult to watch shares of CYDY that have been in a downward decline for nearly most of the time I've been invested. I too have been able to average down but not into the high .30's but around .495 so I feel your pain as much as mine.
BUT, as for an exit strategy, once Combo is approved, I will ride this much further and sell only a small position but not after Combo but will wait til the CTC's show something positive and watch what it does to the shares and then will still hold for there is just too much science with so many indications to pull out too soon so I will wait til another indication is proved out like MS. Too me, that will tell us whether or not shares will continue their ascent to even higher highs and then I would exit maybe a bit less than half of my investment and ride the rest for other cancer successes - GLTU
HCIT
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...
Continue Reading
New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...
Continue Reading
Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...
Continue Reading
Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...
Continue Reading
Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...
Continue Reading
Understanding the Invisible Threat of Crawl Space Mold Crawl space mold—it hides in the shadows beneath your home, biding its time until it wreaks havoc on indoor air quality. In the context of New Jersey's environmental quirks, this isn't a trivial concern. With humidity hanging around like an unwanted guest and sneaky water intrusions, those dark nooks under houses...
Continue Reading
Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...
Continue Reading
Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...
Continue Reading
The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...
Continue Reading
The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...
Continue Reading
Top 5 Most Recently Viewed Articles
Teleflex Completes Strategic Acquisition to Enhance Portfolio Teleflex Incorporated (NYSE: TFX), a renowned name in medical technology, proudly announces the successful completion of its acquisition of BIOTRONIK's Vascular Intervention business. This acquisition significantly bolsters Teleflex's interventional access portfolio and extends its influence in the cath lab,...
Continue Reading
Mattamy Homes Continues to Shine as a Leading Employer Award-winning homebuilder, Mattamy Homes, has been recognized for its exceptional workplace culture, securing the title of one of South Florida's Best Places to Work for the third consecutive year. This significant recognition comes from the South Florida Business Journal, which highlights companies excelling in team...
Continue Reading
Community Efforts to Replant Trees This month marks an important milestone for Asheville residents as the Arbor Day Foundation embarks on an ambitious mission to distribute 1,200 trees. This initiative is part of a larger effort to distribute a remarkable total of 10 million trees, aimed at supporting recovery for those affected by the devastating Hurricanes Helene and...
Continue Reading
Chevron Tops the List of Shorted Securities in August The latest Shortside Crowdedness Report from Hazeltree reveals that Chevron was the most shorted stock in the Americas for August. This indicates a significant trend among market players who are eager to exploit short selling opportunities. Hazeltree, renowned for its expertise in treasury operations and smart...
Continue Reading
Regal Rexnord Corporation Upcoming Earnings Conference Call Regal Rexnord Corporation (NYSE: RRX) is preparing to share its financial journey with stakeholders, announcing an important earnings conference call scheduled for Thursday, October 30, 2025. The company plans to release its financial results on the eve of the call, ensuring that investors and analysts alike are...
Continue Reading